Pediatric and Young Adult GIST Data
Pediatric GIST overview | Pediatric GIST Data | Pediatric GIST FAQs | Radiation Risks for Pediatric Patients |
Pediatric GIST References/Links | Pediatric GIST Presentations |
NIH Pediatric GIST Clinic
To join the Pediatric GIST listserv, go to: Pediatric GIST listserv
Reports - All under 30 | Carney's Triad | Pediatric GIST (under 18) | 18 to 24 years old | 25 to 30 years old
Life Raft Group Data
This table lists all of the Life Raft Group members under the age of 30. It is important to note that this group consists of several subgroups; under 18, Carney's Triad, 18 to 2 and 25 to 30. The natural course of the disease will vary between these subtypes and between individual patients.
Patient ID |
Gender |
Misdiagnosed Gist? |
Original Cancer Diagnosis |
Age at diagnosis |
GIST Type | Mutation |
Location of Primary Tumor at Diagnosis | Current age |
Current Treatment |
| PG-131 | F |
FALSE |
GIST |
11.2 |
Carney's Triad | Wildtype |
Stomach | 14.1 |
None |
| PG-106 | F |
FALSE |
GIST |
12.6 |
Carney's Triad | Wildtype |
Stomach | 18.7 |
None |
| PG-115 | F |
FALSE |
GIST |
14.4 |
Carney's Triad | Wildtype |
Stomach | 17.1 |
None, Mets debulked |
| PG-125 | F |
TRUE |
LMS |
14.9 |
Carney's Triad | Wildtype |
Stomach | 30.0 |
Gleevec 800 mg (long-term) |
| PG-109 | F |
TRUE |
GIST |
15.9 |
Carney's Triad | Wildtype |
Stomach | 21.0 |
None |
| PG-133 | F |
FALSE |
GIST |
28.9 |
Carney's Triad | Wildtype |
Stomach | 30.2 |
Sutent 31.5 mg (Alternates 37.5 & 25) |
| PG-148 | F |
FALSE |
GIST |
30.4 |
Carney's Triad | Stomach | 34.4 |
? | |
| PG-136 | F |
FALSE |
GIST |
34.1 |
Carney's Triad | Wildtype |
Stomach | 34.5 |
None, has chondromas |
| PG-122 | M |
FALSE |
GIST |
17.9 |
Familial | Kit, exon 11 |
Small Bowel | 19.3 |
None, NED |
| PG-120 | F |
TRUE |
Other |
7.7 |
GIST | Wildtype |
Stomach | 9.8 |
None, NED |
| PG-103 | F |
FALSE |
GIST |
8.2 |
GIST | Wildtype |
Stomach | 12.0 |
Sutent 25 mg 4/2 schedule |
| PG-124 | F |
FALSE |
GIST |
9.8 |
GIST | Stomach | 11.4 |
None, NED | |
| PG-137 | M |
FALSE |
GIST |
10.0 |
GIST | Unknown | 10.5 |
None, NED | |
| PG-110 | F |
FALSE |
GIST |
10.0 |
GIST | Wildtype |
Stomach | 15.4 |
Sutent 37.5 mg 4/2 schedule |
| PG-111 | F |
TRUE |
LMS |
10.4 |
GIST | Wildtype |
Stomach | 22.4 |
None NED |
| PG-127 | F |
FALSE |
GIST |
10.8 |
GIST | Stomach | 15.7 |
None, 1 esophageal tumor remaining | |
| PG-112 | M |
FALSE |
GIST |
12.3 |
GIST | Stomach | 17.1 |
None, mets | |
| PG-107 | F |
TRUE |
LMS |
12.4 |
GIST | Wildtype |
Stomach | 24.7 |
Gleevec |
| PG-121 | F |
TRUE |
LMS |
12.8 |
GIST | Stomach | 31.6 |
None? | |
| PG-104 | F |
FALSE |
GIST |
13.3 |
GIST | Stomach | 17.7 |
None, NED | |
| PG-114 | M |
FALSE |
GIST |
14.0 |
GIST | Stomach | 16.5 |
Gleevec 600 mg, mets | |
| PG-101 | F |
FALSE |
GIST |
15.3 |
GIST | Stomach | 20.6 |
Sutent 12.5 mg | |
| PG-132 | M |
FALSE |
GIST |
16.1 |
GIST | Wildtype |
Stomach | 16.5 |
Gleevec 500 mg |
| PG-135 | M |
FALSE |
GIST |
18.0 |
GIST | Wildtype |
Stomach | 19.6 |
None, NED |
| PG-117 | F |
TRUE |
Other |
19.2 |
GIST | Stomach | 32.2 |
Gleevec 400 mg | |
| PG-118 | M |
FALSE |
GIST |
19.3 |
GIST | Stomach | 22.3 |
none, finished adjuvant Gleevec (1 yr) | |
| PG-139 | F |
FALSE |
GIST |
19.5 |
GIST | Stomach | 21.1 |
Neoadjuvant Gleevec 800 mg | |
| PG-100 | F |
FALSE |
GIST |
19.6 |
GIST | Stomach | 23.3 |
None | |
| PG-138 | F |
TRUE |
Other |
19.9 |
GIST | Wildtype |
Stomach | 34.5 |
Sutent 31.5 mg (Alternates 37.5 & 25) |
| PG-108 | F |
TRUE |
Other |
20.3 |
GIST | Small Bowel | 29.0 |
None, NED | |
| PG-102 | F |
FALSE |
GIST |
20.6 |
GIST | Stomach | 25.8 |
Deceased | |
| PG-105 | F |
FALSE |
GIST |
21.0 |
GIST | Wildtype |
Stomach | 25.5 |
Sutent 50 mg 4/2 schedule |
| PG-130 | F |
FALSE |
GIST |
21.1 |
GIST | Stomach | 21.8 |
Gleevec | |
| PG-126 | M |
FALSE |
GIST |
21.8 |
GIST | Small Bowel | 23.0 |
Gleevec 400 mg adjuvant | |
| PG-149 | F |
FALSE |
GIST |
22.6 |
GIST | Stomach | 31.5 |
Deceased | |
| PG-116 | M |
FALSE |
GIST |
23.1 |
GIST | Liver | 26.1 |
Deceased | |
| PG-147 | F |
TRUE |
LMS |
23.7 |
GIST | Stomach | 39.9 |
Deceased | |
| PG-128 | M |
FALSE |
GIST |
23.9 |
GIST | Stomach | 27.7 |
Gleevec + Rapamycin | |
| PG-129 | F |
FALSE |
GIST |
24.6 |
GIST | Stomach | 30.7 |
Gleevec + Rapamycin | |
| PG-123 | F |
TRUE |
Other |
25.1 |
GIST | Wildtype |
Stomach | 42.3 |
None |
| PG-134 | M |
TRUE |
Other |
26.0 |
GIST | Small Bowel | 35.2 |
Sutent 50 mg | |
| PG-150 | F |
FALSE |
GIST |
26.3 |
GIST | Small Bowel | 30.0 |
Gleevec 800 mg | |
| PG-152 | M |
TRUE |
Other |
26.6 |
GIST | Large Bowel | 28.4 |
Gleevec 800 mg (responding well) | |
| PG-141 | F |
FALSE |
GIST |
26.7 |
GIST | Small Bowel | 28.8 |
None, NED | |
| PG-142 | F |
FALSE |
GIST |
27.1 |
GIST | Kit, exon 9 |
Small Bowel | 28.3 |
Gleevec 600 mg adjuvant |
| PG-154 | M |
FALSE |
GIST |
27.6 |
GIST | Small Bowel | 30.6 |
None, took adjuvant Gleevec for almost 3 years | |
| PG-145 | M |
FALSE |
GIST |
27.7 |
GIST | Stomach | 27.9 |
Sutent | |
| PG-146 | M |
FALSE |
GIST |
28.2 |
GIST | Stomach | 30.2 |
None | |
| PG-155 | M |
FALSE |
GIST |
28.2 |
GIST | 36.9 |
None | ||
| PG-143 | F |
FALSE |
GIST |
28.5 |
GIST | Abdomen | 31.0 |
None, NED | |
| PG-153 | F |
FALSE |
GIST |
28.8 |
GIST | Small Bowel | 33.1 |
none, had mets, now NED | |
| PG-144 | F |
FALSE |
GIST |
28.9 |
GIST | Stomach | 28.9 |
None, NED | |
| PG-140 | M |
FALSE |
GIST |
29.1 |
GIST | Kit |
Small Bowel | 31.7 |
Deceased |
| PG-156 | F |
FALSE |
GIST |
29.7 |
GIST | Stomach | 35.4 |
Sutent 37.5 mg 4/2 schedule | |
| PG-151 | F |
GIST |
GIST | Stomach | Deceased | ||||
| PG-157 | M |
Deceased | |||||||
1. Gastrointestinal Stromal Tumors
in Children and Young Adults.
A Clinicopathologic, Molecular, and Genomic Study
of 15 Cases and Review of the Literature. J Pediatr Hematol Oncol Volume 27, Number 4, April 2005. Sonam Prakash, MD, Lisa Sarran, MS, Nicholas Socci, PhD,
Ronald P. DeMatteo, MD, Jonathan Eisenstat, MD, Alba M. Greco, MD,
Robert G. Maki, MD, PhD,{ Leonard H. Wexler, MD,k Michael P. LaQuaglia, MD,
Peter Besmer, PhD, and Cristina R. Antonescu, MD




